FORA Capital’s Akcea Therapeutics Inc AKCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-1,765
Closed -$32K 1209
2020
Q3
$32K Buy
+1,765
New +$25K 0.02% 516

FORA Capital's AKCA Position: Q4 2020 in Review

FORA Capital sold out of Akcea Therapeutics Inc (AKCA) in Q4 2020, closing a stake of 1,765 shares — an estimated $32K sold.

FORA Capital first reported a position in AKCA in Q3 2020 and held it in 1 quarter. The position peaked at $32K in Q3 2020. 0 funds tracked by Wall St. Rank hold AKCA as of Q4 2020.

  • FORA Capital reported no remaining Akcea Therapeutics Inc position as of Q4 2020 after selling out during the quarter.
  • FORA Capital sold 1,765 Akcea Therapeutics Inc shares in Q4 2020, an estimated $32K.
  • FORA Capital first reported a position in Akcea Therapeutics Inc in Q3 2020 and held it in 1 quarter.
  • FORA Capital's Akcea Therapeutics Inc position peaked at $32K in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Akcea Therapeutics Inc as of Q4 2020.

Based on FORA Capital's 13F filing for Q4 2020, filed 12 Feb 2021.